<DOC>
	<DOC>NCT01126320</DOC>
	<brief_summary>Ventilator Associated Pneumonia (VAP) is a common complication experienced by mechanically ventilated patients and within the framework of Respiratory Intensive Care Units. The AnapnoGuard system, developed by Hospitech Respiration Ltd. is a ventilation guard system that includes a number of unique characteristics. This study was designed to test the frequency VAP in mechanically ventilated ICU patients using the AnapnoGuard System.</brief_summary>
	<brief_title>Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated Patients Using the AnapnoGuard System</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
	<criteria>ICU patients; Patient was connected to AnapnoGuard system up to six hours from intubation; Age above 18. Pneumonia; Aspiration Pneumonia; Chronic or Severe Pneumonia; Chronic Obstructive Pulmonary Disease (COPD) requiring permanent homebased antibiotic treatment; Interstitial Lung Disease (ILD); Post Lung Transplant State; Immunosuppression. Patients ventilated in prone position Patient who was ventilated 3 months prior to being enrolled in the study Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>VAP</keyword>
</DOC>